Actemra (tocilizumab) is an interleukin-6 (IL-6) receptor antagonist. This biologic therapy is used to treat a variety of inflammatory conditions.
Actemra has been shown to reduce inflammation and swelling, slow the progression of joint damage, reduce joint tenderness, and ease everyday activities.
Actemra works by blocking the receptor sites for IL-6. IL-6 is a protein that can cause inflammation of the body’s immune cells. Blocking this process helps to reduce pain, swelling and inflammation.
Click here for additional side effects
Before your infusion, it is important to drink plenty of water and come to your appointment hydrated. Additionally, you must alert us as soon as possible to any changes in your insurance to ensure that we are still an in-network provider for your infusion therapy.